Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
ProGeLife logo — Innovative research solutions for rare diseases

ProGeLife

Innovative research solutions for rare diseases

Founded 2014 9 employees Non Equity Assistance Health Care, Health and Wellness +2

General Information

Company Name ProGeLife
Founded Year 2014
Employees 9
Industries Health Care, Health and Wellness, Sports +1
Funding Stage Non Equity Assistance
Social

Get notified when ProGeLife moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ProGeLife

ProGeLife is a startup that focuses on developing drugs for the treatment of rare genetic diseases with premature or accelerated aging. The company was founded in 2014 and operates in the industries of Health Care, Health and Wellness, Sports, and Wellness Beauty. Although the headquarters location is not specified, ProGeLife received non-equity assistance investment from Incubateur Impulse on 03 July 2015. The company's slogan "Innovative research solutions for rare diseases" aptly summarizes its core focus and mission, positioning it as a potential player in the biopharmaceutical industry.

Taxonomy: Rare Diseases, Genetic Diseases, Drug Development, Therapeutics, Cosmetics, Accelerated Aging, Medical Research, Pharmaceuticals, Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
03 Jul 2015

ProGeLife Alternatives & Competitors

ProGeLife vs
Intercept Pharmaceuticals
Intercept Pharmaceuticals United States

Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.

Post Ipo Debt
376 employees
Biotechnology, Health Care
ProGeLife vs
Vandria SA
Vandria SA Switzerland

We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic...

Grant
14 employees
Manufacturing, Pharmaceutical
ProGeLife vs
CENSO BIOTECHNOLOGIES LTD
CENSO BIOTECHNOLOGIES LTD

A leading CRO with unparalleled expertise in intricate cell biology, focusing on human neurodegenera...

Series Unknown
1 employees
Biotechnology

FAQ About ProGeLife

Innovative research solutions for rare diseases
ProGeLife was founded in 2014.
ProGeLife operates in the following industries: Health Care, Health and Wellness, Sports, Wellness Beauty.
ProGeLife has approximately 9 employees.
ProGeLife has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to ProGeLife include Intercept Pharmaceuticals, Vandria SA, CENSO BIOTECHNOLOGIES LTD, Rubedo Life Sciences, Antlia Bioscience, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ProGeLife and Intercept Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ProGeLife and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy